CR 20-080 Hearing Information

Notice of Hearing

The Controlled Substances Board announces that it will hold a public hearing on a permanent rule for CSB 4 relating to designating Gabapentin as a monitored drug at the time and place shown below.

Hearing Information

Date:     January 15, 2021

Time:     9:30 AM

Location:   Virtual Hearing—Connection information will be posted in advance of the hearing at the following webpage: https://dsps.wi.gov/Pages/RulesStatutes/PublicHearingComments.aspx

Appearances at the Hearing and Submittal of Written Comments

Comments may be submitted to Jon Derenne, Administrative Rules Coordinator, Department of Safety and Professional Services, Division of Policy Development, 4822 Madison Yards Way, Madison, WI 53708-8366, or by email to [e-mail]. Comments shall be received on or before the time of the hearing scheduled for January 15, 2021 at 9:30 AM to be included in the record of rule-making proceedings.

The rule may be reviewed and comments made at:

http://docs.legis.wisconsin.gov/code/chr/hearings.

Initial Regulatory Flexibility Analysis

The proposed rule will not have an effect on small businesses, as defined under s. 227.114 (1).

Agency Small Business Regulatory Coordinator

Daniel Hereth, [e-mail], [phone]